# Epidemiology & Cancer Control (ECC) Research Program

> **NIH NIH P30** · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2020 · $32,500

## Abstract

ABSTRACT
The vision of the Epidemiology and Cancer Control Program (ECC) is to reduce the cancer burden in the PCC
catchment area and beyond. To achieve this vision, we aim to conduct innovative and high impact research,
discovering risk factors and translating this knowledge into effective cancer control. Under the dynamic new
leadership of Jiyoung Ahn and Donna Shelley, ECC organizes its research efforts into four complementary
thematic aims: Aim1: to discover and effectively control cancer-causing microbial risk factors; Aim 2: to assess
and effectively control environmental and behavioral risk factors; Aim 3: to improve early detection and risk
prediction for high-risk individuals; and Aim 4: to optimize cancer care delivery to patients through health
services research. The Program is composed of 33 members and 11 associate members from 12 academic
departments in the NYU School of Medicine (NYUSoM), particularly our new Department of Population Health,
as well as the NYU College of Nursing, College of Dentistry, and the new College of Global Public Health. ECC
members currently have 60 funded projects totaling $10.5M in annual direct costs, $2.7M from NCI (39% of
peer-reviewed funding). Our members are highly collaborative, as indicated by 21% intra- and 33% inter-
programmatic collaborations, 33% inter-institutional collaborations (with other NCI-CCs), and 22 multi-PI grants.
Program members published 686 papers in the current period, including many in top tier journals, such as
NEJM, Lancet, and JAMA Pediatrics (15% of publications [n=102] have IF>10). Our signature research on the
microbiome has led to novel discoveries of cancer-causing microbial risk factors, published in JAMA Oncology,
Gut, JNCI and already cited more than 250 times; these paradigm-shifting hypotheses on microbial
contribution to these malignancies have also fueled translation to clinical trials and new avenues of basic
science research. Our work on developing innovative smoking control methods and assessing air pollution—
cancer risk relationships impacted major health policy locally in our catchment area and nationally. Our health
services research, including studies of optimized imaging use and active surveillance, helped inform standard
guidelines of care for prostate cancer patients. ECC has continued to make exceptionally high impact scientific
contributions, with particular attention to the needs of our unique catchment area.

## Key facts

- **NIH application ID:** 9867650
- **Project number:** 5P30CA016087-39
- **Recipient organization:** NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- **Principal Investigator:** Jiyoung Ahn
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $32,500
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9867650

## Citation

> US National Institutes of Health, RePORTER application 9867650, Epidemiology & Cancer Control (ECC) Research Program (5P30CA016087-39). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9867650. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*